nPhase, IQVIA and others rebuild clinical development around AI, data foundations and agents
Between September 7 and 11, nPhase launched an AI-native platform for clinical trial data management, and IQVIA is rebuilding clinical development around AI. Brainomix's AI imaging enriched the phase 2a IPF trial data of Endeavor BioMedicines.
Who is affected and how
- pharmaceuticals
- Putting trial data foundations and governance in order is a prerequisite for adopting AI.
Sources
- User | thepilotnews.com - nPhase Launches Industry’s First AI-Native Enterprise Platform for End-to-End Clinical Data Management: nPhase.aibusiness.thepilotnews.com · Sep 8, 2026
- nPhase launches AI clinical data management platform to soup up sponsor trial designfiercebiotech.com · Sep 9, 2026
- How is AI Supporting Clinical Trial Design? | PharmExecpharmexec.com · Sep 10, 2026
- IQVIA Rebuilds Clinical Development Around AI. The Regulatory Stack Learns to Draft Itself. The Lab Bench Gets Wired to the Agent.newsletter.lifesciences.digital · Sep 7, 2026
- Building the Data Foundation for AI-Driven Clinical Development | AllSciapp.allsci.com · Sep 8, 2026
- AI in clinical trials: Building better trials before they startpharmaphorum · Sep 8, 2026
- AI in clinical trials: Building better trials before they start | pharmaphorumpharmaphorum.com · Sep 8, 2026
- AI-enabled clinical trialsnature · Sep 10, 2026
Machine-generated summary based on the titles and excerpts of the source articles. The source article is the authority for the facts. News monitoring, not medical advice: consult a doctor for health decisions.